🔗 Share this article

An underground economy for unlicensed weight-loss medications is propelled by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Investigational Drug Acquiring Traction Online

The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Followers are urged to message these profiles privately for supplier links, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Separately, a flourishing market exists on messaging services, where groups with numerous of participants share “before and after” images, injection guides and assertions of rapid UK delivery. Vendors market the substance there before directing buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Experts Voice Worries

However, doctors and pharmacists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting substances of uncertain source.

Some experts said the popularity for retatrutide could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, prosecution or prison.

Platform Reaction and Content Removal

According to the social media company, the platform has taken down violative material and prohibited associated keywords and search suggestions. The company said it was committed to maintaining the platform secure and investing in enhancing enforcement strategies.

Online Trading Activities

Investigations also found groups with up to 9,000 participants selling the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up channels with numerous of users, filled with images of slimming results, positive reviews and step-by-step instructions for mixing or administering at home.

Within minutes of joining one group, a seller posted contact information, where most transactions occur. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about weight, health issues or previous experience.

Product Information and Pricing

Inside these groups, messages show black plastic parcels with postal service labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20 milligrams. When asked how long a injector should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for Telegram said it regularly monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they can’t verify. Even if the research behind retatrutide is valid, these digital versions may not include what they advertise,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her team has already seen individuals injured by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company investigational product not yet approved … may expose users to possibly significant health risks”.